References
- Buchanan N, Roland KB, Rodriguez JL, et al (2013). Opportunities for public health communication, intervention, and future research on breast cancer in younger women. J Womens Health, 22, 293-8. https://doi.org/10.1089/jwh.2012.4239
- Cao WM, Wang XJ, Li JC (2013). Hereditary breast cancer in the han Chinese population. J Epidemiol, 23, 75-84.
- Chen W, Zheng R, Zhang S, et al (2013). The incidences and mortalities of major cancers in China, 2009. Chin J Cancer, 32, 106-12. https://doi.org/10.5732/cjc.013.10018
- Cheng F, Zhang Q, Liu WH, et al (2010). Clinicopathologic analysis of 2019 breast cancer patients with Han and Uygur nationalities in Xinjiang areas. Cancer Res Prev Treat, 7, 1312-4.
- Colleoni M, Rotmensz N, Robertson C, et al (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol, 13, 273-9.
- Couch FJ (2004). Genetic epidemiology of BRCA1. Cancer Biol Ther, 3, 509-14. https://doi.org/10.4161/cbt.3.6.840
- Cui J, Hopper JL (2000). Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study. Cancer Epidemiol Biomarkers Prev, 9, 805-12.
- Ferlay J, Bray F, Pisani P, et al (2004). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 version 2.0, IARC Press, Lyon.
- Fitzgerald MG, Macdonald DJ, Krainer M, et al (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med, 334, 143-9. https://doi.org/10.1056/NEJM199601183340302
- Ford D1, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994). Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet, 343, 692-5. https://doi.org/10.1016/S0140-6736(94)91578-4
- Friedman LS, Ostermeyer EA, Szabo CI, et al (1994). Confirmation of BRCAl by analysis of gremlin mutations linked to breast and ovarian cancer in ten families. Nature Genetics, 8, 399-404. https://doi.org/10.1038/ng1294-399
- Hall MJ, Reid JE, Burbdge LA, et al (2009). BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast ovarian cancer. Cancer, 115, 2222-33. https://doi.org/10.1002/cncr.24200
- Hansa J, Kannan R, Ghosh SK (2012). Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from North-East India. Asian Pac J Cancer Prev, 13, 5871-4. https://doi.org/10.7314/APJCP.2012.13.11.5871
- Huang J, Tang LL, Hu Z, et al (2008). BRCA1 and BRCA2 gene mutations of familial breast cancer and early-onset breast cancer from Hunan province in China. Zhongguo Ai Zheng Za Zhi, 18, 566-72.
- Laraqui A, Uhrhammer N, Lahlou-amine I, et al (2013). Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population. Int J Med Sci, 10, 60-7. https://doi.org/10.7150/ijms.5014
- Li SW, Lu Y, Yang XY, et al (2012). Analysis of clinical characteristics and related factors of breast cancer patients with different nationalities in Xinjiang areas. J Xinjiang Med University, 35, 895-8.
- Li WF, Hu Z, Rao NY, et al (2008). The prevalence of BRCA1 and BRCA2 germline mutations in high risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat, 110, 99-109. https://doi.org/10.1007/s10549-007-9708-3
- Meindl A (2002). Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer, 97, 472-80. https://doi.org/10.1002/ijc.1626
- Meng J, Shi YR, Niu RF, et al (2009). Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer. Zhonghua Yi Xue Za Zhi, 89, 79-82.
- Miki Y, Swensen J, Shattuck-Eidens D, et a1 (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCAl. Science, 266, 66-71. https://doi.org/10.1126/science.7545954
- Mohammad Mahdi Kooshyar, Mohammadreza Nassiri, Morteza Mahdavi, et al (2013). Identification of germline BRCA1 mutations among breast cancer families in northeastern Iran. Asian Pac J Cancer Prev, 14, 4339-45. https://doi.org/10.7314/APJCP.2013.14.7.4339
- Musoplino A, Bella MA, Bortesi B, et al (2007). BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. Breast, 16, 280-92. https://doi.org/10.1016/j.breast.2006.12.003
- Ou JH , Wu T, Sijmons R, et al (2013). Prevalence of BRCA1 and BRCA2 germline mutations in breast cancer women of multiple ethnic region in Northwest China. J Breast Cancer, 16, 50-4. https://doi.org/10.4048/jbc.2013.16.1.50
- Parkin DM (2004). International variation. Oncogene, 23, 6329-40. https://doi.org/10.1038/sj.onc.1207726
- Suter NM, Ray RM, Hu YW, et al (2004). BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev, 13, 181-9. https://doi.org/10.1158/1055-9965.EPI-03-0196
- Tang NL, Pang CP, Yeo W, et al (1999). Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst, 91, 882-5. https://doi.org/10.1093/jnci/91.10.882
- Thirthagiri E, Lee SY, Kang P, et al (2008). Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian ountry (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res, 10, 59.
- Tohg T, Kang P, Lee SS, et al (2008). BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history. PLoS One, 3, 2024. https://doi.org/10.1371/journal.pone.0002024
- Uhrhammer N, Abdelouahab A, Laffarge l, et al (2008). BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases. Int J Med Sci, 5, 197-202.
- Wooster R, Weber BL (2003). Genomic medicine: breast and ovarian cancer. N Engl J Med, 348, 2339-47. https://doi.org/10.1056/NEJMra012284
- Yassaee VR, Zeinali S, Harirchi I, et al (2002). Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res, 4, 6. https://doi.org/10.1186/bcr519
Cited by
- Targeted Resequencing of 30 Genes Improves the Detection of Deleterious Mutations in South Indian Women with Breast and/or Ovarian Cancers vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5211
- BRCA1 and BRCA2 Common Mutations in Iranian Breast Cancer Patients: a Meta Analysis vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1219
- Genetic Variants Associated with Clinicopathological Profiles in Sporadic Breast Cancer in Sri Lankan Women vol.21, pp.2, 2018, https://doi.org/10.4048/jbc.2018.21.2.165